Medical Policy
Policy Num: 09.003.007
Policy Name: CONTACT LENSES FOR THE PEDIATRIC POPULATION
Policy ID: [09.003.007][Ar L M+ P+][0.00.00]
Last Review: November 10, 2021
Next Review: N/A
Issue: November, 2021
Archived
Related Policies: N/A
Popultation Reference No. | Populations | Interventions | Comparators | Outcomes |
---|---|---|---|---|
1 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
2 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
3 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
4 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
5 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
6 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
7 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
8 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
9 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
10 | Individuals:
| Interventions of interest are:
| Comparators of interest are:
| Relevant outcomes include:
|
It is estimated that 40.9 million people over the age of 18 in the United States (one in six adults) wear contact lenses, 93 percent wear soft lenses and the rest have gas-permeable lenses.
Contact lenses can be classified by their composition material, time of use, total time of use, permeability, water content, and type of correction. With many types of new lenses available, there are alternatives to help most patients achieve the use of comfortable lenses with clear vision. New types of contact lenses are being introduced continuously with the intention of reducing the risks of infection, inflammation and trauma of the conjunctiva and maximize vision correction and comfort of use
Soft lenses are made of different plastic polymers that absorb water (hydrophilic). These materials differ in terms of oxygen permeability (expressed in Dk units, where D is diffusion and k for solubility), water content (which varies between 20 and 70 percent water by weight), quality of the surface (wettability), ultraviolet absorption, and structural consistency (rigidity or modulus). The Food and Drug Administration of the United States (FDA) has developed a classification system for soft lenses.
The maintenance of a smooth and transparent refraction anterior surface is fundamental for good vision. A complex interaction between the cornea and the conjunctival epithelium, the tear film, and the overlapping eyelids offers protection against infection and scarring. Noninfectious complications are minimized with a contact lens with an adjustment that is both based on the pre-corneal tear film and moves just enough to allow good fluid and gas exchange, thereby functioning as a de facto extension of the ocular surface.
N/A
Contact lenses are considered for payment for any of the following indications:
A. Congenital aphakia
B. Acquired aphakia after cataract surgery (adult or pediatric);
C. Irregular corneas / corneal scarring when vision cannot be corrected with glasses (for example, keratoconus, after corneal graft surgery, after corneal infection);
D. As a corneal dressing to promote wound healing (eg, corneal ulcer / erosion, keratitis);
E. Refractive errors that cannot be corrected at a sharpness level of 20/40 with glasses.
F. Amblyopia when cannot be corrected otherwise.
Contact lenses are not considered for payment for the following conditions:
A. Albinism - as an alternative to polarized glasses to reduce sensitivity to light or severe photophobia;
B. Amblyopia- as an alternative to eye patches therapy / traditional pathing of the eye / occlusion or
C. Prior authorization in the correction of refractive errors instead of glasses, except as indicated above.
Preauthorization is required for the entire contact lens service.
Contact lenses used in the treatment of an eye medical condition covered by the benefit of eye care and low vision services for Medicaid, Family Health Plus and Child Health Plus members.
a. Contact lenses for Medicaid members are eligible for coverage once every 24 months, unless there has been a change in vision that requires a change in prescription or the lenses have been lost or damaged.
b. Contact lenses for Family Health Plus members are eligible for coverage once every 24 months.
c. Contact Lenses for Child Heath Plus members are eligible for coverage once every 12 months
Multiple contact lens changes may be necessary in pediatric patients with aphakia whether acquired or congenital.
Contact lens application must include all the following characteristics:
a. documentation of medical necessity
b. better corrected vision with and without the lenses
c. better corrected vision with and without contact lenses
d. date of the last complete examination of the eyes
e. refractive error.
BlueCard/National Account Issues
N/A
N/A
N/A
Population Reference No. 1-6 Policy Statement
1) congenital aphakia,
2) acquired aphakia after cataract surgery (adult or pediatric),
3) irregular corneas or corneal scarring when vision cannot be corrected with glasses,
4) corneal ulcer or erosion or keratitis,
5) refractive errors that cannot be corrected at a sharpness level of 20/40 with glasses,
6) amblyopia when cannot be corrected otherwise treated with Rx contact lenses.
Relevant outcomes include better corrected vision, promote wound healing and correct refractive errors that cannot be corrected otherwise. The evidence is sufficient to determine that the technology results in a meaningful improvement in the net health outcome.
Population Reference No. 1-6 Policy Statement | [X] MedicallyNecessary | [ ] Investigational | [ ] Not Medically Necessary |
Population Reference No. 7-10 Policy Statement
For individuals with:
7) albinism (as an alternative to polarized glasses to reduce sensitivity to ligh)t
8) albinism (with severe photophobia),
9) amblyopia (as an alternative to eye patches therapy / traditional pathing of the eye / occlusion),
10) correction of refractive errors instead of glasses, except as indicated treated with Rx contact lense.
Evidence suggest no additional medical benefit of using this technology when compared to other therapies available.
Population Reference No. 7-10 Policy Statement | [ ] MedicallyNecessary | [ ] Investigational | [X] Not Medically Necessary |
N/A
N/A
N/A
1. Cope JR, Collier SA, Rao MM, et al. Contact Lens Wearer Demographics and Risk Behaviors for Contact Lens-Related Eye Infections--United States, 2014. MMWR Morb Mortal Wkly Rep 2015; 64:865.
2. Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses: a case-control study. Ophthalmology 2008; 115:1647
Codes | Number | Description |
---|---|---|
HCPCS | V2599 | Contact lens, other type |
ICD-10-CM | H16.001-H16.003 | Unspecified corneal ulcer (code range) |
H16.011-H16.013 | Central corneal ulcer (code range) | |
H16.021-H16.023 | Ring corneal ulcer (code range) | |
H16.031-H16.033 | Corneal ulcer with hypopyon (code range) | |
H16.041-H16.043 | Marginal corneal ulcer (code range) | |
H16.051-H16.053 | Mooren's corneal ulcer (code range) | |
H16.061-H16.063 | Mycotic corneal ulcer (code range) | |
H16.071-H16.073 | Perforated corneal ulcer (code range) | |
H16.101-H16.103 | Other and unspecified superficial keratitis without conjunctivitis (code range) | |
H16.111-H16.113 | Macular keratitis (code range) | |
H16.121-H16.123 | Filamentary keratitis (code range) | |
H16.131-H16.133 | Photokeratitis (code range) | |
H16.141-H16.143 | Punctate keratitis (code range) | |
H17.01-H17.03 | Adherent leukoma (code range) | |
H17.11-H17.13 | Central corneal opacity (code range) | |
H17.811-H17.813 | minor opacity of cornea (code range) | |
H17.821-H17.823 | Peripheral opacity of cornea (code range) | |
H17.89 | Other corneal scars and opacities | |
H17.9 | Unspecified corneal scar and opacity | |
H18.601-H18.603 | Keratoconus, unspecified (code range) | |
H18.611-H18.613 | Keratoconus, stable (code range) | |
H18.621-H18.623 | Keratoconus, unstable (code range) | |
H18.711-H18.713 | Corneal ectasia (code range) | |
H18.721-H18.723 | Corneal staphyloma (code range) | |
H18.731-H18.733 | Descemetocele (code range) | |
H18.791-H18.793 | Other corneal deformities | |
H25.011-H25.013 | Age-related cataract (code range) | |
H25.031-H25.033 | Anterior subcapsular polar age-related cataract (code range) | |
H25.041-H25.043 | Posterior subcapsular polar age-related cataract (code range) | |
H25.091-H25.093 | Other age-related incipient cataract (code range) | |
H25.11-H25.13 | Age-related nuclear cataract (code range) | |
H25.21-H25.23 | Age-related cataract, morgagnian type (code range) | |
H25.811-H25.813 | Combined forms of age-related cataract (code range) | |
H25.89 | Other age-related cataract | |
H25.9 | Unspecified age-related cataract | |
H26.001-H26.003 | Infantile and juvenile cataract (code range) | |
H26.011-H26.013 | Unspecified infantile and juvenile cataract (code range) | |
H26.031-H26.033 | Infantile and juvenile nuclear cataract (code range) | |
H26.041-H26.043 | Anterior subcapsular polar infantile and juvenile cataract (code range) | |
H26.051-H26.053 | Posterior subcapsular polar infantile and juvenile cataract (code range) | |
H26.061-H26.063 | Combined forms of infantile and juvenile cataract (code range) | |
H26.09 | Other infantile and juvenile cataract | |
H26.9 | Unspecified cataract | |
H27.01-H27.03 | Aphakia (code range) | |
Q12.3 | Congenital aphakia | |
H53.011-H53.013 | Deprivation amblyopia (code range) | |
H53.021-H53.023 | Refractive amblyopia (code range) | |
H53.031-H53.033 | Strabismic amblyopia (code range) |
Some modifiers
Date | Action | Description |
---|---|---|
11/10/2021 | Annual Revision - Archived | Policy reviewed at Physician Advisory Board. No changes in policy statement. Policy approved for archival. |
11/11/2020 | Annual Revision | Policy reviewed at Provider Advisory Committee. No changes in policy statement. |
11/14/2019 | Annual Revision | Policy reviwed at Provider Advisory Committee. No changes. |
11/14/2018 | Review | added amblyopia PICO and code range. Edited policy statement. Policy reviwed at Provider Advisory Committee 14 nov 2018 |
03/29/17 | ||
06/10/2016 | ||
06/08/2016 | ||
04/01/16 | New Policy |